2013-02-05T13:32:30Z
2013-02-05T13:32:30Z
2012-05-25
2013-02-05T13:32:30Z
It has been previously described that p21 functions not only as a CDK inhibitor but also as a transcriptional co-repressor in some systems. To investigate the roles of p21 in transcriptional control, we studied the gene expression changes in two human cell systems. Using a human leukemia cell line (K562) with inducible p21 expression and human primary keratinocytes with adenoviral-mediated p21 expression, we carried out microarray-based gene expression profiling. We found that p21 rapidly and strongly repressed the mRNA levels of a number of genes involved in cell cycle and mitosis. One of the most strongly down-regulated genes was CCNE2 (cyclin E2 gene). Mutational analysis in K562 cells showed that the N-terminal region of p21 is required for repression of gene expression of CCNE2 and other genes. Chromatin immunoprecipitation assays indicated that p21 was bound to human CCNE2 and other p21-repressed genes gene in the vicinity of the transcription start site. Moreover, p21 repressed human CCNE2 promoter-luciferase constructs in K562 cells. Bioinformatic analysis revealed that the CDE motif is present in most of the promoters of the p21-regulated genes. Altogether, the results suggest that p21 exerts a repressive effect on a relevant number of genes controlling S phase and mitosis. Thus, p21 activity as inhibitor of cell cycle progression would be mediated not only by the inhibition of CDKs but also by the transcriptional down-regulation of key genes.
Article
Versió publicada
Anglès
Mitosi; Bioinformàtica; Expressió gènica; Mitosis; Bioinformatics; Gene expression
Public Library of Science (PLoS)
Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0037759
PLoS One, 2012, vol. 7, num. 5, p. e37759
http://dx.doi.org/10.1371/journal.pone.0037759
cc-by (c) Ferrándiz, N. et al., 2012
http://creativecommons.org/licenses/by/3.0/es
Biomedicina [779]